180 related articles for article (PubMed ID: 37923984)
1. Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint.
Liu Y; Huang Y; Zhu D; Li J; Zhao T; He Y; Xia R; Zhong L
BMC Cancer; 2023 Nov; 23(1):1062. PubMed ID: 37923984
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study.
Mastboom MJL; Palmerini E; Verspoor FGM; Rueten-Budde AJ; Stacchiotti S; Staals EL; Schaap GR; Jutte PC; Aston W; Gelderblom H; Leithner A; Dammerer D; Takeuchi A; Thio Q; Niu X; Wunder JS; ; van de Sande MAJ
Lancet Oncol; 2019 Jun; 20(6):877-886. PubMed ID: 31029509
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunohistochemical analysis of diffuse tenosynovial giant cell tumour of the temporomandibular joint.
Wang DD; Luo HY; Guo CB; Meng JH
Int J Oral Maxillofac Surg; 2020 Jul; 49(7):882-888. PubMed ID: 32014315
[TBL] [Abstract][Full Text] [Related]
4. Chondroid tenosynovial giant cell tumour: a rarity in the temporomandibular joint.
Biyani P; Khurram SA; Thomas M; Nusrath M
Br J Oral Maxillofac Surg; 2019 Apr; 57(3):282-284. PubMed ID: 30904202
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of diffuse tenosynovial giant cell tumor arising from temporomandibular joints].
Meng JH; Guo YX; Luo HY; Guo CB; Ma XC
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1049-1054. PubMed ID: 27987512
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated With Postoperative Recurrence in Patients With Tenosynovial Giant Cell Tumor of the Hand: A Retrospective Cohort Study.
Shi J; Zheng J; Zhou X; Li Z; Chen X; Gao W; Yan H
Ann Plast Surg; 2019 Nov; 83(5):523-528. PubMed ID: 31524641
[TBL] [Abstract][Full Text] [Related]
7. Uncommon tumors of temporomandibular joint: An institutional experience and review.
Hamza A; Gidley PW; Learned KO; Hanna EY; Bell D
Head Neck; 2020 Aug; 42(8):1859-1873. PubMed ID: 32040228
[TBL] [Abstract][Full Text] [Related]
8. Incomplete resection increases the risk of local recurrence and negatively affects functional outcome in patients with tenosynovial giant cell tumor of the hindfoot.
Tsukamoto S; Zucchini R; Staals EL; Mavrogenis AF; Akahane M; Palmerini E; Errani C; Tanaka Y
Foot Ankle Surg; 2020 Oct; 26(7):822-827. PubMed ID: 31839476
[TBL] [Abstract][Full Text] [Related]
9. Management of tenosynovial giant cell tumour of the temporomandibular joint: a systematic review.
Kanbour A; Hurrell M; Ricciardo P
ANZ J Surg; 2023 Apr; 93(4):869-875. PubMed ID: 37052058
[TBL] [Abstract][Full Text] [Related]
10. Malignant Tenosynovial Giant Cell Tumor: The True "Synovial Sarcoma?" A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes.
Al-Ibraheemi A; Ahrens WA; Fritchie K; Dong J; Oliveira AM; Balzer B; Folpe AL
Mod Pathol; 2019 Feb; 32(2):242-251. PubMed ID: 30206409
[TBL] [Abstract][Full Text] [Related]
11. Tenosynovial giant cell tumors of the temporomandibular joint and lateral skull base: Review of 11 cases.
Carlson ML; Osetinsky LM; Alon EE; Inwards CY; Lane JI; Moore EJ
Laryngoscope; 2017 Oct; 127(10):2340-2346. PubMed ID: 27888510
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
Nakayama R; Jagannathan JP; Ramaiya N; Ferrone ML; Raut CP; Ready JE; Hornick JL; Wagner AJ
BMC Cancer; 2018 Dec; 18(1):1296. PubMed ID: 30594158
[TBL] [Abstract][Full Text] [Related]
13. Tenosynovial giant cell tumor: a case report.
Ansel S; Yan X; Chong P; Lo S; McCleery M; Mahendra A; MacDuff E; Cowie F; Nixon I; White J;
J Med Case Rep; 2023 Oct; 17(1):419. PubMed ID: 37798760
[TBL] [Abstract][Full Text] [Related]
14. Tumor location and type affect local recurrence and joint damage in tenosynovial giant cell tumor: a multi-center study.
Ota T; Nishida Y; Ikuta K; Tsukushi S; Yamada K; Kozawa E; Urakawa H; Imagama S
Sci Rep; 2021 Aug; 11(1):17384. PubMed ID: 34462509
[TBL] [Abstract][Full Text] [Related]
15. Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
Kitagawa Y; Takai S
J Nippon Med Sch; 2020 Sep; 87(4):184-190. PubMed ID: 32350187
[TBL] [Abstract][Full Text] [Related]
16. Prediction of local recurrence in tenosynovial giant cell tumor of the knee: Based on preoperative MRI evaluation into disease subtypes and severity.
Kim JH; Lee SK; Kim JY
PLoS One; 2023; 18(6):e0287028. PubMed ID: 37315053
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Related Factors of Tumor Recurrence or Progression After Transnasal Sphenoidal Surgical Treatment of Large and Giant Pituitary Adenomas and Establish a Nomogram to Predict Tumor Prognosis.
Chen Y; Cai F; Cao J; Gao F; Lv Y; Tang Y; Zhang A; Yan W; Wang Y; Hu X; Chen S; Dong X; Zhang J; Wu Q
Front Endocrinol (Lausanne); 2021; 12():793337. PubMed ID: 34970226
[TBL] [Abstract][Full Text] [Related]
18. Tenosynovial Giant Cell Tumor of Temporomandibular Joint and Skull Base Presenting as Ear Canal Mass.
Vassalli G; Vassalli L; Black M; Lim JH
Ear Nose Throat J; 2020 Mar; 99(3):190-191. PubMed ID: 30955370
[No Abstract] [Full Text] [Related]
19. Diffuse Tenosynovial Giant Cell Tumor Around the Temporomandibular Joint: An Entity With Special Radiologic and Pathologic Features.
Wang JG; Liu J; He B; Gao L; Zhang L; Liu J
J Oral Maxillofac Surg; 2019 May; 77(5):1022.e1-1022.e39. PubMed ID: 30796908
[TBL] [Abstract][Full Text] [Related]
20. Diffuse-Type Tenosynovial Giant Cell Tumor Arising in the Temporomandibular Joint Extending to the External Auditory Canal: A Case Report and Literature Review.
Suzuki S; Tsuda H; Bandoh N; Goto T; Uemura A; Aoyama T; Nishio A; Makino S; Yamaguchi T; Aimono E; Nishihara H; Harabuchi Y
Ear Nose Throat J; 2023 May; 102(5):291-296. PubMed ID: 33752465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
